NIH-funded research Career grant

How gut bacteria affect brain cell barriers

Official title: Impact of the Gut Microbiome on Astrocyte Barrier Function

Funded at Icahn School of Medicine at Mount Sinai · NIH-10909795 · Data updated 2026-11-12

This study is looking at how the bacteria in your gut might affect brain health, especially for people with multiple sclerosis, by exploring how certain gut bacteria can help protect brain cells and reduce inflammation.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$282,108
NIH project number5K01NS133057-02
Project IDNIH-10909795 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with multiple sclerosis or related neurological conditions.

Less likely to help

Patients with neurological disorders unrelated to the gut microbiome may not receive benefit from this research.

What this research studies

This research investigates the relationship between gut microbiome and the function of astrocytes, which are crucial cells in the brain that help maintain the blood-brain barrier. The study focuses on how specific gut bacteria, particularly those that produce butyrate, can influence neuroinflammation and potentially improve conditions like multiple sclerosis. By examining both preclinical models and clinical data, the research aims to uncover mechanisms that could lead to new therapeutic strategies for neurological disorders. Patients may benefit from insights into how gut health impacts brain function and disease progression.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that harness the gut microbiome to improve brain health and manage neurological diseases.

How similar studies have gone: Previous studies have shown promising results in understanding the gut-brain axis, indicating that this approach could yield significant insights.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Tankou, Stephanie — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Tankou, Stephanie

Related research

Other NIH-funded projects on the same topics.

  • Multi-agent AI to annotate enzymes in the human gut microbiome

    A team at a major university will build an AI system that automatically curates and labels the functions of enzymes in the human gut microbiome to speed up understanding their health effects.

    NIH research University of South Florida · Tampa, United States · NIH-11594384

  • Mapping how gut bacteria transform drugs

    Scientists will study how the gut microbiome changes thousands of drugs into new forms, which could affect how well a medicine works or whether it causes side effects.

    NIH research Stanford University · Stanford, United States · NIH-11550022

  • Aflatoxin exposure and child growth in Guatemala

    A study in rural Guatemala will track how exposure to aflatoxin relates to growth and gut health in young children.

    NIH research Arizona State University-Tempe Campus · Scottsdale, United States · NIH-11513260

  • Gut bacteria that can make cancer immunotherapy less effective

    This project will see if reducing chronic inflammation driven by certain gut bacteria can help immunotherapy work better for people whose cancers have stopped responding.

    NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11478145

  • How gut bacteria affect how cancer drugs work

    This project looks at how the bacteria in your gut might change how well and with what side effects fluoropyrimidine cancer drugs like 5-FU work in people.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473234

  • Gut bacteria and cancer drugs: how your gut may change chemotherapy effectiveness

    This project studies how the gut microbiome might affect how well certain chemotherapy drugs work and their side effects in people with cancer.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473233

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.